Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/openWorld/idempotent annotations, the description discloses important behaviors: ambiguous company name matches return figi_candidates without asserting a single result, unresolvable identifiers are explicitly listed under unresolved rather than omitted, and LEI/FIGI enrichment degrades gracefully when upstream sources are unavailable. This is exactly the kind of behavioral context an agent needs before invoking the tool.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but it earns its length by covering multiple identifier systems, input formats, fallback behavior, and a common failure mode. It is front-loaded with the core purpose and usage trigger, and the later detail is organized by supported entity types. The main weakness is that it reads as a dense wall of parentheticals rather than a more scannable structured format.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with only two required parameters and no output schema, the description is remarkably complete. It specifies all accepted inputs, explains how each entity type resolves, and describes ambiguity and failure behavior well enough for an agent to call it correctly and interpret non-obvious results. Nothing essential for selection or invocation appears to be missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description adds substantial meaning: it gives concrete value examples for both types, explains what form 'value' takes for companies (ticker, CIK, or name), clarifies brand vs generic drug names, and warns against passing full noun phrases like 'NEW YORK ST DORM AUTH revenue bonds'. This goes well beyond the schema's short descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user-phrase examples and then states the core action: resolving a user-spoken name to canonical/official identifiers that other tools require as input. It names specific identifier types (CIK, ticker, LEI, FIGI, RxCUI) and supported entity types, making the tool's purpose unmistakable and distinguishable from generic lookup or profile tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit directive: 'Use FIRST whenever you have a name but need an ID.' It also explains that this tool replaces 2-3 manual lookups, which clarifies its role in a multi-step workflow. However, it does not name sibling tools as alternatives or state explicit when-not-to-use scenarios, so it stops short of full alternative routing.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation3/5

Descriptions are unusually explicit about when to use each tool (single lookup vs grounded vs deep research), but the set still contains several genuinely overlapping tools: ask_pipeworx_beta is explicitly identical to ask_pipeworx, scan_competitor_ai_presence wraps ai_visibility, and six polymarket_* tools share the same 'edge/arbitrage' conceptual space. An agent can usually pick the right tool but faces real ambiguity in several clusters.

Naming Consistency4/5

Names are uniformly snake_case and readable, and there are coherent prefix families (ask_pipeworx_*, polymarket_*, pipeworx_*). However the verb placement is inconsistent: verb_noun (ask_pipeworx, validate_claim, discover_tools) coexists with noun-first names (recent_changes, entity_compare, layer_info, polymarket_edges), and bet_research sits outside the polymarket_* family despite being a prediction-market tool.

Tool Count2/5

34 tools is well past the 'feels heavy' threshold, and more importantly the set mixes what looks like three different servers: a tiny ArcGIS/Longview GIS slice (layer_info, query_layer, search_datasets), a massive general-purpose data-research platform from Pipeworx, and a Polymarket prediction-market toolkit. Most tools earn their place for the platform, but far too few belong to the named domain.

Completeness4/5

The research surface is remarkably complete: a router, grounded and beta variants, deep multi-source research, claim verification, entity/profile/change resolution, discovery and suggestion helpers, memory (remember/recall/forget), subscriptions (subscribe/unsubscribe/recent_alerts), and feedback — no obvious lifecycle dead ends. Minute gaps exist on the GIS side (no dataset editing, no metadata browsing, no named export/view ops) and a few nooks like screen- leisure tools have no progress/status endpoints, but these are workaroundable.